FTC sues key pharmacy profit managers over insulin rates The agency introduced motion towards Caremark, Convey Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating procedures “artificially inflated” the record cost of lifestyle-saving insulin drugs. Insurers will keep on vertically integrating to keep more revenue in-dwelling, and federal scrutiny https://ayahealthcareaddress97407.goabroadblog.com/30008523/new-step-by-step-map-for-healthcare-news